NIPRO Debuts New Reverse Osmosis Pure Water Dialysis System

NIPRO has launched LiniXia, a strategic addition to its dialysis portfolio in next-generation reverse-osmosis (RO) water treatment. The new LiniXia RO green-generation water treatment system produces water with the necessary quality for every dialysis session, and was developed with feedback from international technicians and healthcare staff active in dialysis care.

LiniXia offers the next generation in reverse-osmosis water treatment, providing a responsive, reliable, resource-optimizing, high-yield solution for dialysis clinics, according to the company. The addition of LiniXia PRO—NIPRO’s first RO system with full heat disinfection—positions the company as a full provider in water treatment, completing its renal care portfolio as a total solutions provider in haemodialysis treatment. The new LiniXia system combines safety, reliability and digital integration in a walk-up system that is intuitive for dialysis care providing permeate for dialysis treatment.

Anticipating dialysis care’s evolving needs, LiniXia was developed by incorporating feedback from clinic technicians and healthcare teams. LiniXia’s design is accessible and intuitive to both healthcare staff and technicians, ensuring continuous production of permeate, and optimized use of water and energy resources based on clinical demands. 

For more than 20 years, NIPRO’s water treatment experts at its NPW plant in Bruchsal, Germany, have designed and manufactured RO water treatment solutions. The company achieved EU Medical Device Regulation (MDR) 2017/745 certification for its RO systems last year.   

LiniXia’s semi-open design gives clinics oversight at a glance, featuring a closed front with a user-friendly operating system and open rear access for technician-friendly hands-on inspection or maintenance.

LiniXia minimizes downtime with smart warning management, automatically restarting when the power returns after an outage, automatically switching on command from double to single stage, and can produce permeate by key, if necessary, as an emergency override. Conductivity target setup ensures customizable permeate conductivity. Disinfection (full heat and/or chemical, depending on variant) is confirmed by an A0 target. 

LiniXia’s volume tank is adjustable, fills and heats only when required, and otherwise remains empty, optimizing water and power usage. Frequency-controlled pumps provide permeate adapted to demand. LiniXia can provide up to 90% yield of permeate.

NIPRO Medical Europe is a total solutions provider for haemodialysis treatment, supplying life-saving technologies to healthcare providers, building long-term, meaningful partnerships with clinics and hospitals worldwide. NIPRO Europe Group Companies is part of NIPRO Corporation Japan, a leading global healthcare company founded in 1954 in Osaka with close to 40,000 colleagues worldwide. NIPRO Corporation serves the medical device, pharmaceutical, pharma packaging and regenerative medicine sectors.